Infigratinib hydrochloride(1310746-15-6)
- Name: Infigratinib hydrochloride
- Synonyms:Infigratinib hydrochloride;BGJ-398 hydrochloride;UNII-WY8VD4RV77;WY8VD4RV77;1310746-15-6;Urea, N'-(2,6-dichloro-3,5-dimethoxyphenyl)-N-(6-((4-(4-ethyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)-N-methyl-, hydrochloride (1:1);INFIGRATINIB HYDROCHLORIDE [WHO-DD];Q27293042
- Molecular Formula:C26H32Cl3N7O3
- Molecular Weight:596.9
- CAS Registry Number:1310746-15-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1261960-28-4/5-(3-Carbamoyl-4-chlorophenyl)-2-chloroisonicotinic acid
- 1233513-34-2/(S)-4-Bromo-homo-ibotenic acid
- 136655-57-7/BQ-123 sodium
- 1039647-38-5/1H-Imidazole-2-carboxylic acid hydrochloride
- 1297344-66-1/3-(1H-imidazol-2-yl)prop-2-enoic acid hydrochloride
- 1297344-68-3/(2Z)-3-(1H-imidazol-2-yl)prop-2-enoic acid hydrochloride, Z
- 97148-40-8/azanium;(2E)-2-(furan-2-yl)-2-methoxyiminoacetate
- 1245642-82-3/5-Fluoro-2-[(4-methylphenyl)amino]-4(3H)-pyrimidinone
- 82356-84-1/Cystine, methyl ester
- 1310540-14-7/4,8,15,19,26-Pentamethyl-3,7,14,18,25-pentaoxa-11,22,27,28,29,30,31-heptazahexacyclo[22.2.1.12,5.16,9.113,16.117,20]hentriaconta-1(26),2(31),4,6(30),8,13(29),15,17(28),19,24(27)-decaene-10,21-dione
- 1058742-40-7/2',4'-Difluoro-3-{[4-nitro-3-(trifluoromethyl)phenyl]carbamoyl}[1,1'-biphenyl]-4-yl 3-methylbenzoate
- 1058742-39-4/2',4'-Difluoro-3-{[4-nitro-3-(trifluoromethyl)phenyl]carbamoyl}[1,1'-biphenyl]-4-yl 2-chlorobenzoate
- 1058742-43-0/2',4'-Difluoro-3-{[4-nitro-3-(trifluoromethyl)phenyl]carbamoyl}[1,1'-biphenyl]-4-yl 4-fluorobenzoate
- 1303975-97-4/6-Bromo-3-methylbenzo[d]isothiazole 1,1-dioxide
- 957135-36-3/(3S,6S,1''aS)-6-((S)-2-(Methylamino)propanamido)-N-((1-(2-(2-(2-(2-(4-((S)-((3S,6S,1''aS)-6-((S)-2-(methylamino)propanamido)-5-oxodecahydropyrrolo[1,2-a]azocine-3-carboxamido)(phenyl)methyl)-1H-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)(phenyl)methyl)-5-oxodecahydropyrrolo[1,2-a]azocine-3-carboxamide
- 285996-67-0/2-(acetylamino)-2-deoxy-3-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-glucopyranose
- 2093109-41-0/1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carbonitrile
- 1258934-69-8/Carbamic acid, N-[5-iodo-2-(4-pyridinyl)-4-thiazolyl]-, 1,1-dimethylethyl ester
- 61248-35-9/Deacetylsclerotiorin, (-)-
- 1310746-15-6/Infigratinib hydrochloride
- 1312424-28-4/Benzonitrile, 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-di(methyl-d)phenyl]amino]-2-pyrimidinyl]amino]-
- 1311570-07-6/Rizedisben
- 1208971-05-4/Aftobetin
- 1311385-35-9/Bicyclo(3.1.0)hexane-2,6-dicarboxylic acid, 2-(((2S)-2-amino-1-oxopropyl)amino)-4-(1H-1,2,4-triazol-5-ylthio)-, (1R,2S,4R,5R,6R)-
- 1193111-43-1/4-Azido-2-sulfo-butyric acid
- 1284210-63-4/6-Iodo-3-methylimidazo[1,2-a]pyridine
- 932736-88-4/(-)-Methyl(1S,2R)-2-[(4-Hydroxy-4-phenylpiperidin-1-yl)-methyl]-1-phenylcyclopropanecarboxylate
- 1286793-03-0/5-Acetyl-3,3-difluoroindolin-2-one
- 1312447-02-1/(6R)-6-[(1R,3aS,4E,7aR)-4-{(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyloctahydro-1H-inden-1-yl]-2-methylheptan-2-yl beta-D-glucopyranosiduronic acid
- 1356608-93-9/3H-Furo[3,4-c]pyran-3a(4H)-carboxylic acid, 1,6-dihydro-3-(4-methoxyphenyl)-4-oxo-, ethyl ester